Inventor · disambiguated record
Matthew Moran
Also filed as: MORAN MATTHEW · MORAN MATTHEW D · MORAN MATTHEW DAVID BURR
6 granted patents·4 pending applications·50 citations·filing 2017–2024
83Inventor score
Top patents by PatentIndex Score
10 records- 0195US11541134B1Stabilized compositions of radionuclides and uses thereofRAYZEBIO INC·Filed 2022·Granted Jan 3, 2023·9 cites·14 claims
- 0295US11497822B1Stabilized compositions of radionuclides and uses thereofRAYZEBIO INC·Filed 2022·Granted Nov 15, 2022·11 cites·22 claims
- 0394US11819556B2Stabilized compositions of radionuclides and uses thereofRAYZEBIO INC·Filed 2023·Granted Nov 21, 2023·4 cites·22 claims
- 0494US11707540B2Stabilized compositions of radionuclides and uses thereofRAYZEBIO INC·Filed 2022·Granted Jul 25, 2023·3 cites·19 claims
- 0592US10093741B1IGF-1R monoclonal antibodies and uses thereofFUSION PHARMACEUTICALS INC·Filed 2017·Granted Oct 9, 2018·20 cites·18 claims
- 0684US11433148B2IGF-1R monoclonal antibodies and uses thereofCENTRE FOR PROBE DEV AND COMMERCIALIZATION·Filed 2018·Granted Sep 6, 2022·3 cites·40 claims
- 0782US2024123098A1Stabilized compositions of radionuclides and uses thereofRAYZEBIO INC·Filed 2023·Application pending·0 cites
- 0866US2025064996A1Stabilized compositions of radionuclides and uses thereofRAYZEBIO INC·Filed 2024·Application pending·0 cites
- 0965US2023052140A1Igf-1r monoclonal antibodies and uses thereofCENTRE FOR PROBE DEV AND COMMERCIALIZATION·Filed 2022·Application pending·0 cites
- 1046US2021395281A1Macrocyclic chelates and uses thereofFUSION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew Moran files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →